Key details
Sponsor
Biozeus Biopharmaceutical S.A.
Enrollment target
~72 participants
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years – 65 Years
Last updated October 2024